Authors:
Stringer, JSA
Rouse, DJ
Vermund, SH
Goldenberg, RL
Sinkala, M
Stinnett, AA
Citation: Jsa. Stringer et al., Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa, J ACQ IMM D, 24(4), 2000, pp. 369-377
Authors:
Rittenhouse, BE
Stinnett, AA
Dulisse, B
Henke, CJ
Potter, L
Parasuraman, B
Martens, LL
Williams, RR
Kojak, C
Citation: Be. Rittenhouse et al., An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia, AM J M CARE, 6(3), 2000, pp. 381-389
Authors:
Prosser, LA
Stinnett, AA
Goldman, PA
Williams, LW
Hunink, MGM
Goldman, L
Weinstein, MC
Citation: La. Prosser et al., Cost-effectiveness of cholesterol-lowering therapies according to selectedpatient characteristics, ANN INT MED, 132(10), 2000, pp. 769-779
Citation: Be. Rittenhouse et al., At what price significance? The effect of price estimates on statistical inference in economic evaluation, HEALTH ECON, 8(3), 1999, pp. 213-219
Authors:
Laska, EM
Meisner, M
Siegel, C
Stinnett, AA
Citation: Em. Laska et al., Ratio-based and net benefit-based approaches to health care resource allocation: Proofs of optimality and equivalence, HEALTH ECON, 8(2), 1999, pp. 171-174
Citation: Aa. Stinnett, Is it really so bad to be unambiguously inefficient? The role of dominancein stochastic cost-effectiveness analysis, MED DECIS M, 19(1), 1999, pp. 102-103
Authors:
Cassady, JM
DiPiro, JT
Foster, TS
Hak, LJ
Hill, WT
Kirshstein, R
Lindley, CM
Nahata, MC
Robinson, JR
Stinnett, AA
Murphy, JE
Manasse, HR
Witmer, DR
Citation: Jm. Cassady et al., Report of the ASHP Task Force on Science, AM J HEAL S, 55(23), 1998, pp. 2519-2524